ACT PRAMIPEXOLE 0.25 MG
PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE : 0.25 MG · DIN 02297302 · TEVA CANADA LIMITED
Health Canada status: MARKETED
What is ACT PRAMIPEXOLE?
ACT PRAMIPEXOLE 0.25 MG contains PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE : 0.25 MG. It is listed in the Health Canada Drug Product Database under DIN 02297302, held by TEVA CANADA LIMITED, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 27-Apr-2020. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is ACT PRAMIPEXOLE used for?
ACT PRAMIPEXOLE is indicated for adults for the treatment of the signs and symptoms of idiopathic Parkinson’s disease, both as early therapy without concomitant levodopa and as an adjunct to levodopa. It is also indicated for the symptomatic treatment of moderate to severe idiopathic Restless Legs Syndrome, although its effectiveness for longer than 12 weeks has not been systematically evaluated.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02297302 |
|---|---|
| Brand name | ACT PRAMIPEXOLE |
| Generic / active ingredient | PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE : 0.25 MG |
| Manufacturer | TEVA CANADA LIMITED |
| Strength | 0.25 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | N04BC05 PRAMIPEXOLE |
| AHFS class | 28:36.20.08 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 27-Apr-2020 |
| Original market date | 2009-04-15 00:00:00 |
How is it stored and handled?
null
How is it supplied?
HDPE bottles of 100's
What can be used instead?
Other Canadian products sharing ATC code N04BC05 PRAMIPEXOLE. 29 of 65 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ACT PRAMIPEXOLE | 0.5 MG | TABLET | TEVA CANADA LIMITED | MARKETED | DIN 02297310 |
| ACT PRAMIPEXOLE | 1 MG | TABLET | TEVA CANADA LIMITED | MARKETED | DIN 02297329 |
| ACT PRAMIPEXOLE | 1.5 MG | TABLET | TEVA CANADA LIMITED | MARKETED | DIN 02297337 |
| APO-PRAMIPEXOLE | 0.25 MG | TABLET | APOTEX INC | MARKETED | DIN 02292378 |
| APO-PRAMIPEXOLE | 0.5 MG | TABLET | APOTEX INC | MARKETED | DIN 02292386 |
| APO-PRAMIPEXOLE | 1.0 MG | TABLET | APOTEX INC | MARKETED | DIN 02292394 |
| APO-PRAMIPEXOLE | 1.5 MG | TABLET | APOTEX INC | MARKETED | DIN 02292408 |
| AURO-PRAMIPEXOLE | 0.25 MG | TABLET | AURO PHARMA INC | MARKETED | DIN 02424061 |
| AURO-PRAMIPEXOLE | 0.5 MG | TABLET | AURO PHARMA INC | MARKETED | DIN 02424088 |
| AURO-PRAMIPEXOLE | 1 MG | TABLET | AURO PHARMA INC | MARKETED | DIN 02424096 |
Who else supplies PRAMIPEXOLE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. PRAMIPEXOLE appears in 2459 registered pack listings across 11 markets, published on 10 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.